Crohn's & Colitis Foundation 2022 Midwest Regional Professional Education Program

This course is planned and hosted by the Crohn's & Colitis Foundation. Contact Kelly Fitzgerald, [email protected], for more information.

The Crohn’s & Colitis Foundation 2022 Midwest Regional Professional Education Program is a continuing education program intended for physicians, registered nurses, and advanced practice providers involved in the care of patients with inflammatory bowel disease.  The proposed curriculum will address the most pressing clinical dilemmas in IBD today, as delivered by national faculty, and will draw community clinician audiences from Minnesota, and throughout Illinois, Indiana, Iowa, Nebraska, Wisconsin, and the general region. The program will include a combined session, followed by discipline specific breakouts for physicians and nurses/advanced practice providers.

1. Differentiate between the mechanisms of action, safety, and efficacy of current FDA approved therapies for Crohn’s disease and ulcerative colitis and consider when surgery should be an option.
2. Formulate individualized treatment plans for patients of different ages, genders, and understand the special needs of vulnerable populations.
3. Describe the novel mechanisms of action in current experimental therapies for IBD in approved clinical trials.
4. Identify important health care screenings that pertain to patients with inflammatory bowel disease.

Registration is being handled by the Crohn's & Colitis Foundation. Contact Kelly Fitzgerald, [email protected], for more information.

Credit Designation Statements

American Medical Association (AMA)
The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
This activity is awarded up to 3.75 ANCC contact hours.

Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their certificate of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

Hyatt Regency Bloomington

3200 E 81st St, Bloomington, MN 55425

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Freddy Caldera, DO, MS
University of Wsiconsin-Madison School of Medicine & Public Health

Co-Director, Faculty

Grant or research support-Takeda Pharmaceuticals (Any division)

Byron Vaughn, MD, MS
Associate Professor
University of Minnesota

Course Director, Faculty

Consulting Fee-Prometheus Laboratories, Inc. (Relationship has ended)|Consulting Fee-AbbVie (Any division) (Relationship has ended)|Grant or research support-Takeda Pharmaceuticals (Any division)|Grant or research support-Celgene Corporation|Grant or research support-Diasorin|Grant or research support-Genentech (Any division)

Clark Anderson, PA-C
GI Alliance of Illinois

Faculty

Nothing to disclose

Alye Bedell, PhD
Assistant Professor
University of Chicago

Faculty

Nothing to disclose

David Choi, PharmD, BCACP
Associate Director
University of Chicago Medicine

Faculty

Speakers Bureau-Janssen (Any division)|Consulting Fee-Bristol-Myers Squibb Company (Relationship has ended)|Consulting Fee-Boehringer Ingelheim Pharmaceuticals, Inc.|Consulting Fee-Prometheus Laboratories, Inc.

Nayantara Coelho-Prabhu, MB BS, AGAF, FASGE, FACG
Associate Professor of Medicine
Mayo Clinic

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Alexion Pharmaceuticals|Speakers Bureau-Boston Scientific Corporation

Parimbir S Dulai, MD
Northwestern University

Faculty

Consulting Fee-Takeda Pharmaceuticals (Any division)|Consulting Fee-Pfizer (Any division)|Consulting Fee-AbbVie (Any division)|Consulting Fee-Janssen (Any division)|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Lilly (Any division)|Consulting Fee-Novartis Corporation Pharmaceuticals|Stocks or stock options, excluding diversified mutual funds-Digbihealth|Royalties or Patent Beneficiary-PreciDiag

Sunanda Kane, MD, MS
Professor of Medicine
Mayo Clinic

Faculty

Consulting Fee-Boehringer Ingelheim Pharmaceuticals, Inc.|Advisor-Bristol-Myers Squibb Company|Honoraria-Janssen (Any division) (Relationship has ended)|Consulting Fee-Gilead Sciences, Inc. (Relationship has ended)|Consulting Fee-InveniAI|Consulting Fee-Kinetix Health|Membership on Advisory Committees or Review Panels, Board Membership, etc.-PredictaMed|Consulting Fee-Seres Therapeutics (Relationship has ended)|Consulting Fee-Spherix health (Relationship has ended)|Consulting Fee-TechLab (Relationship has ended)|Consulting Fee-United Healthcare (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-UptoDate|Honoraria-Takeda Pharmaceuticals (Any division)

Edward V. Loftus Jr., MD, FACP, FACG, AGAF
Professor of Medicine
Mayo Clinic College of Medicine and Science

Faculty

Consulting Fee-AbbVie (Any division)|Grant or research support-AbbVie (Any division)|Consulting Fee-Amgen, Inc.|Consulting Fee-Boehringer Ingelheim Pharmaceuticals, Inc.|Grant or research support-Bristol-Myers Squibb Company|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Arena (Relationship has ended)|Consulting Fee-CALIBR (Relationship has ended)|Grant or research support-Celgene Corporation (Relationship has ended)|Consulting Fee-Lilly (Any division)|Consulting Fee-Fresenius Kabi|Consulting Fee-Genentech (Any division)|Grant or research support-Genentech (Any division)|Consulting Fee-Gilead Sciences, Inc.|Grant or research support-Gilead Sciences, Inc.|Consulting Fee-Gossamer Bio|Grant or research support-Gossamer Bio|Consulting Fee-Iterative Scopes|Consulting Fee-Janssen (Any division)|Grant or research support-Janssen (Any division)|Consulting Fee-Morphic|Consulting Fee-Ono Pharma|Grant or research support-Pfizer (Any division)|Consulting Fee-Protagonist|Grant or research support-Receptos (Relationship has ended)|Grant or research support-Alimentiv (Relationship has ended)|Consulting Fee-Takeda Pharmaceuticals (Any division)|Grant or research support-Takeda Pharmaceuticals (Any division)|Grant or research support-Theravance (Relationship has ended)|Consulting Fee-UCB|Grant or research support-UCB

Eugenia Shmidt, MD
University of Minnesota

Faculty

Grant or research support-Bristol-Myers Squibb Company|Grant or research support-UCB

Levi Teigen, PhD, RD
University of Minnesota

Faculty

Nothing to disclose

Noelle Koch, RN, BSN
RN Care Coordinator Lead - Specialty RN
MHealth Fairview

Faculty, Nurse Planner

Nothing to disclose

Michele Rubin, APN, CNS, CGRN, CGRN
Associate Director of IBD Center, University of Chicago Medicine
University of Chicago Medicine

Faculty, Nurse Planner

Nothing to disclose

Ann Bolckom, RN
RN Care Coordinator
M Health Fairview

Nurse Planner

Nothing to disclose

Saturday, September 10, 2022

Exhibit opportunities are available. For more information, contact Kelly Fitzgerald, Crohn's and Colitis Foundation, [email protected].